RxDoctor Payments Data

Michael Madden, DO

Orthopaedic Surgery · Phoenix, AZNPI 1952784100

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.7%. Reporting peaked in 2019 at $2,977 and has fallen 94.2% since, to $172 in 2025.

$7,375in general payments, 2019–2025

Across 58 payments — averaging $127.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sonex Health, Inc.$1K
  • Axogen$1K
  • Arthrex$1K
  • Zimmer Biomet$1K
  • Integra Lifesciences Corporation$959
  • Impactortho, Inc.$385
  • plus $575 from 4 others
$142,331in research payments, 2019–2025

Across 4 payments — averaging $35,583 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sonex Health, Inc.$142K

What the payments were for

  • Speaking & faculty fees$1,25017%
  • Travel & lodging$3,26244%
  • Food & beverage$2,73737%
  • Education$1252%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,375 in reported general payments places this provider in the 55th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$107,054
Medicare patients
162
Services billed
751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl17$100
Meloxicam30$45

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →